Pam Murphy | IR |
Mark Murray | President and CEO |
Mike Sofia | CSO |
David Hastings | CFO |
Liisa Bayko | JMP Securities |
Katherine Xu | William Blair |
Keay Nakae | Chardan |
Good day, ladies and gentlemen, and welcome to Arbutus Biopharma Corporation 2018 Third Quarter Financial Results and Corporate Update. [Operator Instructions] As a reminder this conference is being recorded. I'd now like to introduce your host for today's conference. Ms. Pam Murphy, you may begin.